FKBP10 and lung adenocarcinoma: FKBP10 expression (p = 0.02, HR = 2.472, 95% CI [1.156, 5.289]), targeted therapy (p < 0.01, HR = 0.186, 95% CI [0.073, 0.477]), and radiotherapy (p = 0.006, HR = 0.330, 95% CI [0.149, 0.731]) were found to have an independent prognostic impact on survival of lung adenocarcinoma patients with brain metastases.